
A study investigated the complications associated with new-onset atrial fibrillation (NOAF) in critically ill COVID-19 patients admitted to the ICU. The analysis revealed that patients with NOAF had significantly higher risks of ICU mortality (RR: 1.39, 95% CI: 1.07 – 1.80), in-hospital mortality (RR: 1.56, 95% CI: 1.20 – 2.04), and the need for mechanical ventilation (RR: 1.32, 95% CI: 1.04 – 1.66) compared to those without AF. Additionally, NOAF patients experienced increased risks of acute myocardial infarction (RR: 1.54), acute kidney injury (RR: 1.31), and the need for renal replacement therapy (RR: 1.83). The findings underscore the heightened risk of severe complications and mortality in critically ill COVID-19 patients with NOAF.
Like
Save
Share